Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Blood Loss in Femoral Fracture Surgery
NCT00824564Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in femoral fracture, sponsored by Pfizer. Started Apr 2009; status: completed.
02
Drugs
tranexamic acid
03
Conditions
femoral fracture
Beyond the preview
Go deeper on NCT00824564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824564.